Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Transcoronary and Endocardial Approach

Aksu T., Guler T., Yalin K., Golcuk S. E., Ozcan K.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES, vol.352, no.5, pp.466-471, 2016 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 352 Issue: 5
  • Publication Date: 2016
  • Doi Number: 10.1016/j.amjms.2016.08.025
  • Journal Name: AMERICAN JOURNAL OF THE MEDICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.466-471
  • Keywords: Ablation, Hypertrophic obstructive cardiomyopathy, Septal myectomy, Alcohol septal ablation, Radiofrequency, MYOCARDIAL CONTRAST ECHOCARDIOGRAPHY, RADIOFREQUENCY ABLATION, TRANSRADIAL APPROACH, OUTFLOW OBSTRUCTION, SURGICAL MYECTOMY, REDUCTION THERAPY, TASK-FORCE, CATHETER, CYANOACRYLATE, GUIDELINES
  • Istanbul University-Cerrahpasa Affiliated: Yes

Abstract

Septal reduction therapy is the gold standard treatment method for symptomatic, hypertrophic obstructive cardiomyopathy. Although surgical myectomy is a well-established and effective technique with decades of experience in its application, use of transcoronary alcohol septal ablation has increased precipitously owing to the less-invasive nature of the procedure. Moreover, endocardial septal ablation therapy is a relatively newly defined modality, and outcomes of the procedure are not clearly elucidated yet. In this review, we aimed to present nonsurgical septal reduction approaches in patients with hypertrophic obstructive cardiomyopathy.